Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: Design, synthesis, and biological evaluation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chun, Kwangwoo | - |
dc.contributor.author | Park, Song-Kyu | - |
dc.contributor.author | Kim, Hwan Mook | - |
dc.contributor.author | Choi, Yongseok | - |
dc.contributor.author | Kim, Myung-Hwa | - |
dc.contributor.author | Park, Chun-Ho | - |
dc.contributor.author | Joe, Bo-Young | - |
dc.contributor.author | Chun, Tae Gyu | - |
dc.contributor.author | Choi, Hyun-Moo | - |
dc.contributor.author | Lee, Hee-Yoon | - |
dc.contributor.author | Hong, Sung Hee | - |
dc.contributor.author | Kim, Myung Sook | - |
dc.contributor.author | Nam, Ky-Youb | - |
dc.contributor.author | Han, Gyoonhee | - |
dc.date.accessioned | 2021-09-09T12:49:00Z | - |
dc.date.available | 2021-09-09T12:49:00Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2008-01-01 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/124452 | - |
dc.description.abstract | A series of coumarin types MMP inhibitors were designed based on gelastatin hydroxamates (1) and evaluated for TACE, cellular TNF-alpha, and NO inhibitory activities. Among them, compounds 9b had potent inhibitory activities in enzymatic and cellular assays and good selectivity to MMP-2 and MMP-9. Further investigation of 9b will be carried out for its efficacy in RA animal model system. (c) 2007 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | NECROSIS-FACTOR-ALPHA | - |
dc.subject | CATALYTIC DOMAIN | - |
dc.subject | METALLOPROTEINASE | - |
dc.subject | DISINTEGRIN | - |
dc.title | Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: Design, synthesis, and biological evaluation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Song-Kyu | - |
dc.contributor.affiliatedAuthor | Kim, Hwan Mook | - |
dc.contributor.affiliatedAuthor | Choi, Yongseok | - |
dc.identifier.doi | 10.1016/j.bmc.2007.09.014 | - |
dc.identifier.scopusid | 2-s2.0-38049028622 | - |
dc.identifier.wosid | 000253345400054 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.16, no.1, pp.530 - 535 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 16 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 530 | - |
dc.citation.endPage | 535 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
dc.subject.keywordPlus | CATALYTIC DOMAIN | - |
dc.subject.keywordPlus | METALLOPROTEINASE | - |
dc.subject.keywordPlus | DISINTEGRIN | - |
dc.subject.keywordAuthor | TNF-alpha converting enzyme (TACE) | - |
dc.subject.keywordAuthor | metalloproteinase-2 (MMP-2) | - |
dc.subject.keywordAuthor | metalloproteinase-9 (MMP-9) | - |
dc.subject.keywordAuthor | rheumatoid arthritis (RA) | - |
dc.subject.keywordAuthor | gelastatin hydroxamates | - |
dc.subject.keywordAuthor | coumarin derivatives | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.